| SD |
heart rate |
sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
days
| 6 |
380.0 |
beats/min |
10.0 |
24.49 |
HP Sonos 5500 echo ultrasound |
|
1.0 |
sham ACF |
2 |
days |
|
|
98802 |
2160 |
| WF/Mol |
heart rate |
vehicle control condition then artificial aortocaval fistula (for 9 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 7 |
460.0 |
beats/min |
15.0 |
39.69 |
tail cuff plethysmography |
|
0.0 |
acf |
9 |
days |
|
|
101375 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
377.0 |
beats/min |
11.0 |
26.94 |
tail cuff plethysmography |
|
0.0 |
sham acf |
2 |
days |
|
|
101379 |
2585 |
| WKY/NCrl |
heart rate |
vehicle control condition (for 28 days) and light phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
heart pumping trait |
male |
168.0 days
| 6 |
294.0 |
beats/min |
5.0 |
12.25 |
intra-aortic abdominal radiotelemetry |
|
|
|
|
|
measured 12 hr/day for 4 weeks |
daytime measurement |
103558 |
2827 |
| GK |
heart rate |
vehicle control condition (for 28 days) and light phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
heart pumping trait |
male |
168.0 days
| 6 |
279.0 |
beats/min |
3.0 |
7.35 |
intra-aortic abdominal radiotelemetry |
|
|
|
|
|
measured 12 hr/day for 4 weeks |
daytime measurement |
103560 |
2827 |
| Crlj:WI |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 6 |
351.0 |
beats/min |
19.0 |
46.54 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103043 |
2784 |
| Crlj:WI |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
287.0 |
beats/min |
7.0 |
18.52 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103048 |
2784 |
| GK |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
344.0 |
beats/min |
11.0 |
29.1 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103050 |
2784 |
| Crlj:WI |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 6 |
275.0 |
beats/min |
8.0 |
19.6 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103051 |
2784 |
| Crlj:WI |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
264.0 |
beats/min |
9.0 |
23.81 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103052 |
2784 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
406.0 |
beats/min |
22.0 |
49.19 |
tail cuff plethysmography |
|
0.0 |
sham acf |
4 |
days |
|
|
101369 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
382.0 |
beats/min |
8.0 |
17.89 |
tail cuff plethysmography |
|
0.0 |
sham acf |
7 |
days |
|
|
101388 |
2585 |
| SS-Nppbem2Mcwi-/- |
heart rate |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart pumping trait |
male |
168.0 days
| 7 |
349.0 |
beats/min |
20.0 |
52.92 |
echocardiography |
|
0.0 |
|
|
|
|
|
99818 |
2319 |
| SS/JrHsdMcwi |
heart rate |
vehicle control condition |
Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5. |
heart pumping trait |
male |
56.0 days
| 6 |
358.0 |
beats/min |
7.95 |
19.47 |
vascular fluid filled catheter |
|
0.0 |
|
|
|
|
|
106798 |
3032 |
| Crlj:WI |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
415.0 |
beats/min |
10.0 |
26.46 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103036 |
2784 |
| Crlj:WI |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
379.0 |
beats/min |
9.0 |
23.81 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103042 |
2784 |
| Crlj:WI |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) then meclofenamate (3 mg/kg) (for 0.5 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 6 |
288.0 |
beats/min |
11.0 |
26.94 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103047 |
2784 |
| GK |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 5 |
252.0 |
beats/min |
25.0 |
55.9 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103053 |
2784 |
| WF/Mol |
heart rate |
vehicle control condition then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
460.0 |
beats/min |
9.0 |
22.05 |
tail cuff plethysmography |
|
0.0 |
acf |
4 |
days |
|
|
101368 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then artificial aortocaval fistula (for 2 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
470.0 |
beats/min |
12.0 |
26.83 |
tail cuff plethysmography |
|
0.0 |
acf |
2 |
days |
|
|
101378 |
2585 |
| GK |
heart rate |
vehicle control condition (for 28 days) and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
heart pumping trait |
male |
168.0 days
| 6 |
323.0 |
beats/min |
8.0 |
19.6 |
intra-aortic abdominal radiotelemetry |
|
|
|
|
|
measured 12 hr/night for 4 weeks |
nighttime measurement |
103568 |
2827 |
| GK |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
147.0 |
beats/min |
7.0 |
18.52 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103038 |
2784 |
| GK |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 5 |
301.0 |
beats/min |
21.0 |
46.96 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103049 |
2784 |
| GK |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) then NG-nitroarginine methyl ester (50 mg/kg) (for 0.5 hours) and meclofenamate (3 mg/kg) (for 0.5 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
279.0 |
beats/min |
17.0 |
44.98 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103054 |
2784 |
| SS-Nppbem2Mcwi-/- |
heart rate |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart pumping trait |
male |
252.0 days
| 7 |
327.0 |
beats/min |
19.0 |
50.27 |
echocardiography |
|
0.0 |
|
|
|
|
|
99820 |
2319 |
| SS-Sod3m1Mcwi |
heart rate |
vehicle control condition |
Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5. |
heart pumping trait |
male |
56.0 days
| 8 |
354.0 |
beats/min |
12.9 |
36.49 |
vascular fluid filled catheter |
|
0.0 |
|
|
|
|
|
106799 |
3032 |
| MWF/FubRkb |
heart rate |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
heart pumping trait |
male |
112.0 days
| 10 |
352.3 |
beats/min |
7.3 |
23.08 |
tail cuff plethysmography |
heart |
0.0 |
|
|
|
|
|
109413 |
3140 |
| Crl:WI |
heart rate |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
heart pumping trait |
male |
112.0 days
| 10 |
355.3 |
beats/min |
9.7 |
30.67 |
tail cuff plethysmography |
heart |
0.0 |
|
|
|
|
|
109411 |
3140 |
| SD |
heart rate |
artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
days
| 6 |
420.0 |
beats/min |
14.0 |
34.29 |
HP Sonos 5500 echo ultrasound |
|
1.0 |
ACF |
2 |
days |
|
|
98801 |
2160 |
| Crlj:WI |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 6 |
372.0 |
beats/min |
11.0 |
26.94 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103035 |
2784 |
| GK |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 5 |
395.0 |
beats/min |
17.0 |
38.01 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103037 |
2784 |
| Crlj:WI |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 6 |
90.0 |
beats/min |
15.0 |
36.74 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103039 |
2784 |
| GK |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 5 |
366.0 |
beats/min |
17.0 |
38.01 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103045 |
2784 |
| WF/Mol |
heart rate |
vehicle control condition then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 7 |
450.0 |
beats/min |
13.0 |
34.39 |
tail cuff plethysmography |
|
0.0 |
acf |
7 |
days |
|
|
101372 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
358.0 |
beats/min |
12.0 |
26.83 |
tail cuff plethysmography |
|
0.0 |
sham acf |
7 |
days |
|
|
101373 |
2585 |
| SS-Nppbem2Mcwi-/- |
heart rate |
vehicle control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart pumping trait |
male |
84.0 days
| 7 |
382.0 |
beats/min |
45.0 |
119.06 |
echocardiography |
|
0.0 |
|
|
|
|
|
99816 |
2319 |
| WKY/NCrl |
heart rate |
vehicle control condition (for 28 days) and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
heart pumping trait |
male |
168.0 days
| 6 |
344.0 |
beats/min |
5.0 |
12.25 |
intra-aortic abdominal radiotelemetry |
|
|
|
|
|
measured 12 hr/night for 4 weeks |
nighttime measurement |
103566 |
2827 |
| GK |
heart rate |
controlled air oxygen content (21 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 5 |
366.0 |
beats/min |
17.0 |
38.01 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103041 |
2784 |
| Crlj:WI |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
380.0 |
beats/min |
18.0 |
47.62 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103040 |
2784 |
| Crlj:WI |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
384.0 |
beats/min |
17.0 |
44.98 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103044 |
2784 |
| GK |
heart rate |
controlled air oxygen content (5 %) (for 28 days) then vehicle control condition (0.15 ml) (for 0.1 hours) then acetylcholine (5 ug/kg/min) (for 0.1 hours) then sodium nitroprusside (5 ug/kg/min) (for 0.1 hours) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart pumping trait |
male |
16.0 days
| 7 |
390.0 |
beats/min |
10.0 |
26.46 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
103046 |
2784 |
| WF/Mol |
heart rate |
vehicle control condition then artificial aortocaval fistula (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
448.0 |
beats/min |
10.0 |
24.49 |
tail cuff plethysmography |
|
0.0 |
acf |
4 |
days |
|
|
101382 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then sham surgical control condition (for 4 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 5 |
366.0 |
beats/min |
12.0 |
26.83 |
tail cuff plethysmography |
|
0.0 |
sham acf |
4 |
days |
|
|
101383 |
2585 |
| WF/Mol |
heart rate |
vehicle control condition then artificial aortocaval fistula (for 7 days) |
Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. |
heart pumping trait |
male |
days
| 6 |
448.0 |
beats/min |
7.0 |
17.15 |
tail cuff plethysmography |
|
0.0 |
acf |
7 |
days |
|
|
101387 |
2585 |
| SS.ZUC-Leprfa+/+/Slc |
heart rate |
bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart pumping trait |
female |
91.0 days
| 9 |
380.0 |
beats/min |
8.0 |
24.0 |
tail cuff plethysmography |
|
0.0 |
ovariectomy |
42 |
days |
|
|
101673 |
2622 |
| SS.ZUC-Leprfa-/-/Slc |
heart rate |
bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) |
Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. |
heart pumping trait |
female |
91.0 days
| 8 |
339.0 |
beats/min |
11.0 |
31.11 |
tail cuff plethysmography |
|
0.0 |
ovariectomy |
42 |
days |
|
|
101675 |
2622 |